Pacific Edge (ASX:PEB, NZE:PEB) said it seeks to raise about NZ$20 million through a share placement and share purchase plan, according to a Friday filing with the New Zealand and Australian bourses.
The offer comprises a NZ$15 million placement of new ordinary shares to selected investors and a NZ$5 million retail offer via a share purchase plan, with Pacific Edge reserving the right to accept oversubscriptions in both components at its discretion, the filing said.
The shares are priced at NZ$0.10 each, representing a premium to the 20-day volume-weighted average price.
The capital raise aims to strengthen Pacific Edge's cash reserves to build on recent clinical and commercial milestones, expand in non-Medicare channels, and work toward restoring Medicare coverage that ceased on April 24 following the implementation of the Local Coverage Determination for Genetic testing for Oncology, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.